Form 4: ADC Therapeutics Director Sells Shares to Cover Tax Obligations
SEC Form 4
Jean-Pierre Bizzari, a director of ADC Therapeutics SA, sold 6,995 common shares to cover tax withholding obligations related to the vesting and settlement of restricted share units.
Summary
- On June 17, 2024, Jean-Pierre Bizzari, a director of ADC Therapeutics SA, sold 6,995 common shares of the company.
- The shares were sold at a price of $2.89 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
- Following the transaction, Bizzari directly owns 79,502 common shares.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations) by a company director, which is neither particularly positive nor negative.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation for company directors and executives.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of the share sale transaction. |
| 06/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.